India
· Delayed Price · Currency is INR Alivus Life Sciences Statistics
Total Valuation
NSE:ALIVUS has a market cap or net worth of INR 124.54 billion. The enterprise value is 120.23 billion.
| Market Cap | 124.54B |
| Enterprise Value | 120.23B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:ALIVUS has 122.53 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 122.53M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 7.68% |
| Float | 30.64M |
Valuation Ratios
The trailing PE ratio is 28.28 and the forward PE ratio is 21.70. NSE:ALIVUS's PEG ratio is 1.37.
| PE Ratio | 28.28 |
| Forward PE | 21.70 |
| PS Ratio | 5.48 |
| PB Ratio | 4.91 |
| P/TBV Ratio | 4.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.37 |
Enterprise Valuation
| EV / Earnings | 27.22 |
| EV / Sales | 5.29 |
| EV / EBITDA | 19.27 |
| EV / EBIT | 21.18 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 374.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 14.30% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 11.29M |
| Profits Per Employee | 2.19M |
| Employee Count | 2,014 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.20 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.12 |
| Average Volume (20 Days) | 130,513 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ALIVUS had revenue of INR 22.74 billion and earned 4.42 billion in profits. Earnings per share was 35.93.
| Revenue | 22.74B |
| Gross Profit | 11.99B |
| Operating Income | 5.68B |
| Pretax Income | 5.93B |
| Net Income | 4.42B |
| EBITDA | 6.21B |
| EBIT | 5.68B |
| Earnings Per Share (EPS) | 35.93 |
Balance Sheet
The company has 4.46 billion in cash and 159.77 million in debt, giving a net cash position of 4.30 billion or 35.12 per share.
| Cash & Cash Equivalents | 4.46B |
| Total Debt | 159.77M |
| Net Cash | 4.30B |
| Net Cash Per Share | 35.12 |
| Equity (Book Value) | 25.38B |
| Book Value Per Share | 207.20 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.73%, with operating and profit margins of 24.97% and 19.42%.
| Gross Margin | 52.73% |
| Operating Margin | 24.97% |
| Pretax Margin | 26.06% |
| Profit Margin | 19.42% |
| EBITDA Margin | 27.31% |
| EBIT Margin | 24.97% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 22.50, which amounts to a dividend yield of 2.21%.
| Dividend Per Share | 22.50 |
| Dividend Yield | 2.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | 1.93% |
| Earnings Yield | 3.55% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |